Drug–induced parotitis
Open Access
- 1 August 1993
- journal article
- review article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 18 (4) , 255-258
- https://doi.org/10.1111/j.1365-2710.1993.tb00584.x
Abstract
Drug–induced parotitis is a relatively uncommon adverse drug reaction. Most of the data on drug–induced parotitis consist of isolated case reports with few attempts at rechallenge to confirm the aetiology. Phenylbutazone and oxyphenbutazone have a significant number of reports suggesting that these drugs may be implicated in causing parotitis. Antipsychotics, particularly thioridazine, have been associated with parotitis. Most of these reports relate the anticholinergic oral drying as a predisposing factor in the development of a parotid gland infection. There is inadequate literature on the histamine (H2) receptor blockers, interferon–α, doxycycline, trimipramine, nifedipine, methyldopa, nitrofurantoin, nicardipine, isoproterenol or rito–drine to link them as aetiological agents in the development of parotitis.Keywords
This publication has 23 references indexed in Scilit:
- Case report: Iodide mumps following intravenous urography with iopamidolClinical Radiology, 1991
- Sialadenitis and Systemic Reaction Associated with PhenylbutazoneAustralian and New Zealand Journal of Medicine, 1982
- IODIDE MUMPS AFTER REPEATED EXPOSURE TO IODINATED CONTRAST MEDIAThe Lancet, 1980
- Phenylbutazone-induced sialadenitisOral Surgery, Oral Medicine, Oral Pathology, 1974
- Oxyphenbutazone-Induced ParotitisAnnals of Internal Medicine, 1969
- Hypersensitivity and drug reactions involving the parotid glandBritish Journal of Oral Surgery, 1967
- Salivary Gland Enlargement and PhenylbutazoneBMJ, 1966
- Salivary Gland Enlargement and PhenylbutazoneBMJ, 1966
- Salivary Gland Enlargement and PhenylbutazoneBMJ, 1966
- Salivary Gland Enlargementand PhenylbutazoneBMJ, 1966